Abnormal circulating levels of NAMPT were associated with various musculoskeletal disorders such as osteoporosis, osteoarthritis, and rheumatoid arthritis, suggesting an emerging role of NAMPT as an important biomarker and therapeutic target [20–22]. This evidence concerns the gene NAMPT and rheumatoid arthritis.